SCHEDULE 13G/A

KalVista Pharmaceuticals Inc

Common Stock, par value $0.001 per share · CUSIP: 483497103

Event date: 2025-12-23

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Integrated Core Strategies (US) LLC

  Shares: 2,588,344.00 · Class: 5.1%

• Millennium Management LLC

  Shares: 2,963,699.00 · Class: 5.9%

• Millennium Group Management LLC

  Shares: 2,963,699.00 · Class: 5.9%

• Israel A. Englander

  Shares: 2,963,699.00 · Class: 5.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.